<?xml version="1.0"?>
<Articles JournalTitle="Current Journal of Neurology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.</title>
    <FirstPage>160</FirstPage>
    <LastPage>167</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Roya</FirstName>
        <LastName>Abolfazli</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Elyasi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Javadi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kheirollah</FirstName>
        <LastName>Gholami</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Torkamandi</LastName>
        <affiliation locale="en_US">Department of Pharmaceutical Care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Amir-Shahkarami</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, Isfahan Neurosciences Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Nasr</LastName>
        <affiliation locale="en_US">Department of Medicine, Medical Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; Multiple&#xA0; sclerosis&#xA0; (MS) patients permanently confronted&#xA0; with serious challenges from treatment regimen. Developing&#xA0; a new&#xA0; questionnaire in MS management, through&#xA0; evaluation&#xA0; of patients&#x2019; perspectives&#xA0;&#xA0; and&#xA0; knowledge&#xA0;&#xA0; regarding&#xA0;&#xA0; treatment&#xA0; will help&#xA0; to&#xA0; identify the&#xA0; sources&#xA0; of tension, and&#xA0; to&#xA0; build&#xA0; a therapeutic&#xA0;&#xA0; alliance.&#xA0;&#xA0; We&#xA0;&#xA0; purposed&#xA0;&#xA0; to&#xA0;&#xA0; describe&#xA0;&#xA0;&#xA0; MS patients&#x2019; understanding of their treatments.
Methods: About 425 completed and returned questionnaire were assessed&#xA0; of a total of 500 recruited&#xA0; MS patients. The knowledge&#xA0;&#xA0; of&#xA0; correct&#xA0; using&#xA0; interferon-beta&#xA0; (IFN-&#x3B2;)&#xA0; and attitude&#xA0;&#xA0; toward&#xA0; medical&#xA0; care&#xA0; were&#xA0; assessed&#xA0;&#xA0; using&#xA0; self- reported questionnaires consisted of 25 items with validity of multidisciplinary panel and pre-testing on 20 patients.
Results:&#xA0; Knowledge&#xA0; about&#xA0; IFN-&#x3B2;&#xA0; therapy&#xA0; was&#xA0; very low; however, attitude&#xA0; was at a high level. Female patients, self- injection ability, higher educational level, normal functional status, delay from the start of diagnostic workup to definite diagnosis, and being younger were related to a higher level of&#xA0; knowledge.&#xA0; Attitude&#xA0; was&#xA0; associated&#xA0;&#xA0; with&#xA0; functional status,&#xA0; family&#xA0; history&#xA0; of&#xA0; disease&#xA0;&#xA0; and&#xA0;&#xA0; the&#xA0;&#xA0; summary&#xA0; of knowledge variable.
Conclusion: Developing educational&#xA0; interventions&#xA0; are needed for MS patients&#xA0; regarding&#xA0; to&#xA0; their&#xA0; low levels of knowledge.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/602</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/602/200</pdf_url>
  </Article>
</Articles>
